Rating Agencies
Share recommendations
Made with ❤ von BGFL
#BGFLapp * beta
Valuable background information and well-founded assessments of individual stocks are provided by the studies of the research houses. On this page, Boersengefluester.de (BGFL) provides an integrated overview of all analyst recommendations that come in via the EQS Group newsfeed - enriched with current stock charts as well as meaningful key figure tables and investor information from BGFL. Tip: You are also welcome to use the EQS newsfeed, which we have also enhanced with all the latest company news from our coverage universe.
07.05.2024 09:01AM
Study issued by NuWays AG
q.beyond AG (von NuWays AG): Kaufen
Kaufen
Q1 figures set to display operational improvements / chg.
q.beyond's Q1 figures, which will be released on May 13th, are seen to
provide investors with confidence
regarding the company’s outlook. While top-line growth is expected to come
in rather muted, the imposed efficiency measures should already become
visible on the bottom-line.
Q [ … ]
06.05.2024 09:01AM
Study issued by NuWays AG
elumeo SE (von NuWays AG): Halten
Halten
Mixed Q4 // Weaker-than-expected guidance; est. & PT chg.
elumeo published mixed Q4’23 that continue to be affected by a lingering
macroeconomic slowdown.
Here are our key takeaways:
The company’s FY sales were slightly better than feared, but still burdened
by muted consumer sentiment in the eurozone. Sales for FY came in fla [ … ]
30.04.2024 03:37PM
Study issued by First Berlin Equity Research GmbH
M1 Kliniken AG (von First Berlin Equity Research GmbH): Kaufen
Kaufen
First Berlin Equity Research hat ein Research Update zu M1 Kliniken AG
(ISIN: DE000A0STSQ8) veröffentlicht. Analyst Ellis Acklin bestätigt seine
BUY-Empfehlung und bestätigt sein Kursziel von EUR 18,00.
Zusammenfassung:
Die vorläufigen Ergebnisse für das Jahr 2023 zeigten erneut ein starkes
Ergebnis im Segment Beauty. A [ … ]
29.04.2024 09:12AM
Study issued by NuWays AG
bet-at-home.com AG (von NuWays AG): Halten
Halten
Final FY23 in line // uncertainty from indicative decision
Topic: bet-at-home reported final FY23 figures fully in line with prelims.
Importantly, the report provide us with an update regarding receivables
and liabilities against the Entertainment as well as regarding customer
claims in Austria and Germany. In detail:
Sales came in at € [ … ]
29.04.2024 09:01AM
Study issued by NuWays AG
MAX Automation SE (von NuWays AG): Kaufen
Kaufen
MAX achieved attractive sales price for MA micro; chg. est.
Topic: MAX Automation has come to an agreement on the divestment of its
subsidiary MA micro with an attractive purchase price, sale of MA micro
anticipated in the second half of FY24e.
MAX Automation announced the sale of MA micro (intention was announced in
September 2023), which wa [ … ]
26.04.2024 09:11AM
Study issued by NuWays AG
NFON AG (von NuWays AG): Kaufen
Kaufen
Final FY no surprise after strong prelims / chg.
NFON published final FY 2023 figures, which were in line with the
preliminary results published in early March. FY recurring revenues stood
at € 77.1m, up 4.8% yoy at a continuously strong recurring revenue ratio of
93.7%. This was particularly driven by further key account gains as well as
[ … ]
24.04.2024 09:06AM
Study issued by NuWays AG
OHB SE (von NuWays AG): Verkaufen
Verkaufen
KKR Takeover: still waiting for regulatory approval
Topic: KKR's takeover of OHB's free float still awaits regulatory approval
by three European countries, leading to a estimated closing of the
transaction in Q2/Q3 2024e. Thereafter, a delisting and squeeze-out seems
likely.
FDI approval pending: Most conditions of the takeover are fulfilled, [ … ]
24.04.2024 09:02AM
Study issued by NuWays AG
ZEAL Network SE (von NuWays AG): Kaufen
Kaufen
Q1 preview: EuroJackpot to deliver remarkable top-line
Topic: Q1 results are due May 8th 2024 and we expect ZEAL to show a
remarkable top-line thanks to a superb jackpot environment, leading to
elevated user activity. In detail:
Thanks to the EuroJackpot peaking 4x at the start of Q1, the nationwide
stakes amounted to € 2.07bn in Q1 (Eur [ … ]
24.04.2024 09:01AM
Study issued by NuWays AG
USU Software AG (von NuWays AG): Verkaufen
Verkaufen
Higher than expected offer price still way below intrinsic value
Yesterday, USU announced to have reached a delisting-agreement with AUSUM
GmbH (Udo Strehl) and NUNUS GmbH, a wholly owned subsidiary of AUSUM. While
AUSUM already holds 53.7% of voting rights in USU, NUNUS currently does not
hold any shares. On the basis of the agreement, NUNUS w [ … ]
19.04.2024 09:02AM
Study issued by NuWays AG
MAX Automation SE (von NuWays AG): Kaufen
Kaufen
Positive long-term prospects for Vecoplan and bdtronic
Topic: In recent years, two of the current six portfolio companies
(continuing operations only) became increasingly important. These two
companies, bdtronic and Vecoplan, accounted for 71% of FY23 sales.
Enough reason to have a closer look at their prospects.
Vecoplan: As a global specialis [ … ]
Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
We have summarised companies with a market capitalisation of more than EUR 1 billion that are not included in any index under X-Caps.
Dataselect Tool Family
boersengefluester.de · #BGFL
· © 2024
The news manufactory
Good luck with all your investments
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
Idea & concept: 3R Technologies 
boersengefluester.de GmbH
Copyright © 2024
by Gereon Kruse
#BGFL